Cargando…
Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
INTRODUCTION: Autoantibodies to M-type phospholipase A2 receptor (aPLA2R) are seen in two-thirds of patients with primary membranous nephropathy (PMN) and are associated with disease activity. However, the precise temporal dynamics between the presence and amount of aPLA2R in circulation, as well as...
Autores principales: | Ramachandran, R., Yadav, A.K., Kumar, V., Inamdar, N., Nada, R., Gupta, K.L., Jha, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762964/ https://www.ncbi.nlm.nih.gov/pubmed/29340324 http://dx.doi.org/10.1016/j.ekir.2017.09.001 |
Ejemplares similares
-
The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017) -
The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
por: Kukuy, Olga Lesya, et al.
Publicado: (2023) -
PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016) -
Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016) -
The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)